| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 1e-10 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 7e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.32 | 7e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.23 | 8e-06 |